Viewing StudyNCT06480552

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-07-17 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06480552
Status: RECRUITING
Last Update Posted: 2024-06-28
First Post: 2024-06-10
Brief Title: An Open-label Dose EscalationExpansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Sponsor: Teva Branded Pharmaceutical Products RD Inc
Organization: Teva Branded Pharmaceutical Products RD Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumors
Keywords: